郝亚荣
老年病
发展规划与学科建设办公室主任，二级主任医师，博士生导师
发展规划与学科建设办公室主任，二级主任医师，博士生导师
导师介绍
| 姓名 | 郝亚荣 |
| 出生年月 | 1973年2月 |
| 单位 | 武汉大学人民医院老年病科 |
| 所属学科 | 临床医学-老年医学 |
| 职务、职称及头衔 | 发展规划与学科建设办公室主任，二级主任医师，博士生导师 |
| 984022801@@qq.com | |
| 联系方式 | 027-88041911转86374或15997400765 |
| 研究方向 | 1.代谢综合征的基础与临床研究 2.老年心血管病的基础与临床研究 |
| 个人简介 | 全日制医学博士，加拿大UBC大学高级访问学者。主要从事老年心血管病的临床诊治与科研工作，主持国家及省部级课题12项，参与国际合作项目1项。以第一作者或通讯作者在各级期刊上发表论文70余篇，其中SCI 14篇，主编专著3部，参编专著2部,获湖北省科技进步奖1项、武汉市科技进步奖1项。获国家级发明专利1项。已培养硕士研究生11名，目前正在培养的硕士研究生3名。 |
| 学术任职与荣誉 |
湖北省女医师协会副秘书长
湖北省医学会理事
湖北省老年保健协会理事
湖北省医师协会老年医师分会常委
湖北省微循环学会老年病专业委员会常委
武汉市老年医学会理事 武汉市医师协会理事 《中华临床医师杂志》常务编审 《中国临床药理学杂志》青年编委 |
| 教育履历 |
2018.1.14-2018.1.20新加坡经济管理学院医院管理研修 2013.04-2013.06加拿大UBC大学医学院高级访问学者 2012.09清华大学光华管理学院研修 1996.09-2001.06武汉大学第一临床学院内科学硕博连读研究生获博士学位 1991.09-1996.06山东第一医科大学临床医学专业本科生获学士学位 |
| 工作履历 |
2017.01-至今武汉大学人民医院发展规划与学科建设办公室主任 2008.06-2016.12武汉大学人民医院科教处处长、药物临床试验机构办公室主任 2022.11-至今武汉大学人民医院老年病科二级主任医师、副教授 2011.11-2022.10武汉大学人民医院老年病科主任医师、副教授 2005.11-2011.10武汉大学人民医院老年病科副主任医师、副教授 2001.07-2005.10武汉大学人民医院老年病科主治医师 |
| 成果获奖 |
1.《动脉粥样硬化和代谢综合征发病机制研究和早期临床监测》 2011年获武汉市科技进步二等奖 2.《动脉粥样硬化和代谢综合征发病机制研究和早期临床监测》 2011年获湖北省科技进步三等奖 |
| 代表性论著 |
1．Liao M, Wang Z, Yao J, Xing H, Hao
Y, Qiu B. Identification of potential
biomarkers for papillary thyroid carcinoma by comprehensive bioinformatics
analysis. Mol Cell Biochem. 2023 Jan 12. doi: 10.1007/s11010-022-04606-x 2．Zhang X, Hao YR.Beneficial Effects of Echinacoside on Diabetic Cardiomyopathy in Diabetic Db/Db Mice. Drug Des Devel Ther.2020;14:5575-5587. 3．Xue Zhang, Wan-Qiang Lv , Bo Qiu, Li-Jun Zhang , Jian Qin , Feng-Juan Tang , Hai-Tao Wang, Hua-Jie Li , Ya-Rong Hao.Assessing causal estimates of the association of obesity-related traits with coronary artery disease using a Mendelian randomization approach. Sci Rep . 2018 May;8(1):7146 4. Hao YR , Tang FJ, Zhang X, Wang H. Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice. Biochem Biophys Res Commun .2018 Sep 5;503(2):564-571 5. Zhang, X, Yang, L, Xu, X, Tang, F, Yi, P, Qiu, B. & Hao, Y. "A review of fibroblast growth factor 21 in diabetic cardiomyopathy", Heart Fail Rev, 2019，24（6）：1005-1017. 6. Tang FJ, Hao YR, Zhang X, Qin J. Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy.Drug Des Devel Ther,2017:11,2813-2826 7. Dong X；Zhou H；Zhang Y；Xu M；Hao YR. Apigenin inhibits pressure overload-induced cardiac hypertrophy.INT J CLIN EXP MED，2018，11（4）: 3772-3778 |
| Name | YARONG HAO |
| Date of birth | Feb，1973 |
| Department | Geriatrics Department,Renmin Hospital, Wuhan University. |
| Title | Director, Chief physician, associate professor, doctoral tutor |
| 984022801@qq.com | |
| TEL | 027-88041911-86374 or 15997400765 |
| Research Direction |
1.
Basic and clinical study of metabolic syndrome 2. Basic and clinical study of elder cardiovascular diseases |
| Personal Profile | She graduated from Wuhan University with a Doctor of Philosophy in 2001 and was aseniorvisitingscholarto theUniversity of British Columbia. She is mainly engaged in the diagnosis and treatment of geriatric diseases, and has been awarded 12 items from the Provincial science and Technology Department and the Provincial Health Department. There are more than 70 articles published as the first author or corresponding author, including 14 SCI papers. She has obtained the second prize of Wuhan Science and Technology Progress and the third prize of Hubei Provincial Science and Technology Progress. She has also written 5 books as editor-in-chief and editor. By now, she has educated 11 masters. At present, there are 3 Masters studying with her. |
| Selected Publications |
1．Liao M, Wang Z, Yao J, Xing H, Hao
Y, Qiu B. Identification of potential
biomarkers for papillary thyroid carcinoma by comprehensive bioinformatics
analysis. Mol Cell Biochem. 2023 Jan 12. doi: 10.1007/s11010-022-04606-x 2．Zhang X, Hao YR.Beneficial Effects of Echinacoside on Diabetic Cardiomyopathy in Diabetic Db/Db Mice. Drug Des Devel Ther.2020;14:5575-5587. 3．Xue Zhang, Wan-Qiang Lv , Bo Qiu, Li-Jun Zhang , Jian Qin , Feng-Juan Tang , Hai-Tao Wang, Hua-Jie Li , Ya-Rong Hao.Assessing causal estimates of the association of obesity-related traits with coronary artery disease using a Mendelian randomization approach. Sci Rep . 2018 May;8(1):7146 4. Hao YR , Tang FJ, Zhang X, Wang H. Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice. Biochem Biophys Res Commun .2018 Sep 5;503(2):564-571 5. Zhang, X, Yang, L, Xu, X, Tang, F, Yi, P, Qiu, B. & Hao, Y. "A review of fibroblast growth factor 21 in diabetic cardiomyopathy", Heart Fail Rev, 2019，24（6）：1005-1017. 6. Tang FJ, Hao YR, Zhang X, Qin J. Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy.Drug Des Devel Ther,2017:11,2813-2826 7. Dong X；Zhou H；Zhang Y；Xu M；Hao YR. Apigenin inhibits pressure overload-induced cardiac hypertrophy.INT J CLIN EXP MED，2018，11（4）: 3772-3778 |
武汉大学人民医院
湖北省人民医院